De novo and secondary anaplastic meningiomas: a study of clinical and histomolecular prognostic factors.
Fiche publication
Date publication
juillet 2018
Journal
Neuro-oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr GAUCHOTTE Guillaume
Tous les auteurs :
Peyre M, Gauchotte G, Giry M, Froehlich S, Pallud J, Graillon T, Bielle F, Cazals-Hatem D, Varlet P, Figarella-Branger D, Loiseau H, Kalamarides M
Lien Pubmed
Résumé
Following recent studies underlining the differences between de novo and secondary anaplastic meningiomas and the prognostic value of telomerase reverse transcriptase (TERT) promoter mutation, we decided to conduct a multicenter retrospective study to address these questions and determine specific prognostic factors in each of these 2 anaplastic meningioma subgroups.
Référence
Neuro-oncology. 2018 Jul 5;20(8):1113-1121